Global Stroke Belt

Kim, Anthony; Cahill, Elizabeth A; Cheng, Natalie

doi:10.1161/strokeaha.115.008226

Cited by 117 publications

(40 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Coronary heart disease and cerebrovascular disease, as two major types of cardiovascular disease (CVD), were ranked as the top two caused of premature death and disability-adjusted life-years (DALYs) worldwide [1, 2], and contributed considerably to the increasing healthcare expenditures, especially in low- and middle-income countries, as well as in China [3, 4]. With the rapid economic expansion and increasing average life expectancy, CVD has become the leading cause of death in China, and its morbidity and mortality has been increasing since the late 1980s.…”

Section: Introductionmentioning

confidence: 99%

The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey

Zhang

Xing

et al. 2017

Lipids Health Dis

View full text Add to dashboard Cite

BackgroundDyslipidemia is an important independent modifiable risk factor for cardiovascular disease. The aim of this study was to explore the current prevalence, awareness, treatment and control of dyslipidemia and its associated influence factors in northeast China.MethodsIn this population-based cross-sectional study, we adopted a multi-stage, stratified sampling method to obtain a representative sample of 4052 permanent residents aged 40 years and over from different urban and rural regions in Dehui City of Jilin Province. All subjects completed a questionnaire and were examined for risk factors. Continuous data were presented as means ± standard deviations (SD) and compared using the Student’s t-test. Categorical variables were presented as proportions and compared using the Rao-Scott-χ 2 test in different subgroups. The associated influence factors for the prevalence, awareness, treatment and control of dyslipidemia were evaluated through multivariate logistic regression.ResultsThe prevalence of dyslipidemia was 62.1% overall, with 33.5, 43.9, 0.6, and 8.8% for high total cholesterol, triglyceride, low-density lipoprotein cholesterol, and low high-density lipoprotein cholesterol, respectively. Among those with dyslipidemia, the proportion of subjects who were aware, treated, and controlled was 14.4, 33.9, and 19.9%, respectively. Overweight or obesity (OR = 2.156; 95% CI: 1.863, 2.533), hypertension (OR = 1.643; 95% CI: 1.425, 1.893), or diabetes mellitus (OR = 2.173; 95% CI: 1.661, 2.844) increased the prevalence of dyslipidemia, also these participants were more likely to be aware of their condition, however, this did not increase the likelihood of treatment and control. Living in urban areas and higher education level also increased the awareness of dyslipidemia. Personal history of coronary heart disease was the strongest influence factors associated with better awareness, treatment and control of dyslipidemia. Overweight or obesity (OR = 0.404; 95% CI: 0.235, 0.695) and lack of exercise (OR = 0.423; 95% CI: 0.215, 0.830) were associated with poor control of dyslipidemia.ConclusionThe prevalence of dyslipidemia among adults aged 40 years and over in northeast China was high, however, the awareness, treatment, and control of dyslipidemia was measured at far from desirable levels. Renewed efforts taking influence factors into account are needed to improve the current unsatisfactory condition.

show abstract

Section: Introductionmentioning

confidence: 99%

The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey

Zhang

Xing

et al. 2017

Lipids Health Dis

View full text Add to dashboard Cite

show abstract

“…The disease burden of stroke remains heavy in middle- and low-income countries [14]. Age-standardized stroke mortality in high-income countries, including the United States, Canada, France, Australia, New Zealand, Germany, and Austria ranged from 26.0/100,000 person-years to 32.6/100,000 person-years in 2010 [4,15]. Compared with these high-income countries, stroke mortalities in China appear to be higher [16].…”

Section: Discussionmentioning

confidence: 99%

“…Approximately 6.4 million people died of stroke globally in 2013 [4]. Stroke is currently the leading cause of death in China and contributes to a heavy disease burden [1,5,6].…”

Section: Introductionmentioning

confidence: 99%

Mortality of Stroke and Its Subtypes in China: Results from a Nationwide Population-Based Survey

Chen

Jiang

et al. 2017

Neuroepidemiology

View full text Add to dashboard Cite

Background: In China, stroke is the leading cause of death and contributes to a heavy disease burden. However, a nationwide population-based survey of the mortality of stroke and its subtypes is lacking for this country. Methods: Data derived from the National Epidemiological Survey of Stroke in China, which was a multistage, stratified clustering sampling-designed, cross-sectional survey, were analyzed. Mortality rate analyses were performed for 476,156 participants ≥20 years old from September 1, 2012 to August 31, 2013. Results: Of the 476,156 participants in the investigated population, 364 died of ischemic stroke, 373 of hemorrhagic stroke, and 21 of stroke of undetermined pathological type. The age-standardized mortality rates per 100,000 person-years among those aged ≥20 years were 114.8 for total stroke, 56.5 for ischemic stroke, and 55.8 for hemorrhagic stroke. The age-standardized mortality rates of total stroke, ischemic stroke, and hemorrhagic stroke were all higher in rural areas than those in urban areas. The stroke mortality rate was higher in the northern regions than in the south. An estimated 1.12 million people aged ≥20 years in China died of stroke during the period from September 1, 2012 to August 31, 2013. Conclusions: The burden of stroke in China is still heavy. Greater attention should be paid to improve strategies for preventing stroke.

show abstract

“…Despite continuous progress in prevention and treatment observed over recent decades, stroke remains one of the main causes of death, and the most common cause of long-term disability, in adults in developed countries [1,2].…”

Section: Therapeutic Problemmentioning

confidence: 99%

Statement by a Working Group conceived by the Polish National Consultants in Cardiology and Neurology addressing the use of implantable cardiac monitors in patients after ischaemic embolic stroke of undetermined source

Farkowski

Karliñski

Kaźmierczak

et al. 2018

Neurol Neurochir Pol.

View full text Add to dashboard Cite

Introduction. Stroke remains one of the main causes of death and the most common cause of long-term disability in adults. Embolic strokes of undetermined source (ESUS) amount to a significant proportion of all ischaemic strokes. Detection of atrial fibrillation (AF) in this group of patients would allow for a major therapeutic decision to switch from antiplatelets to oral anticoagulants and therefore significantly reduce the risk of recurrence. State of the Art. Current technology allows long-term continuous ECG monitoring with different systems, including implantable cardiac monitors (ICM). However, in Poland lack of reimbursement does not allow their use in everyday clinical practice. Clinical Implications. This is a statement by a Working Group conceived by the Polish National Consultants in Cardiology and Neurology addressing the use of ICM in patients after ischaemic embolic strokes of undetermined source. The aim was to develop reasonable and comprehensive guidance on how to select and manage candidates for ICM in order to obtain the maximum benefit for Polish public health. Future Directions. This expert opinion is not intended as a guideline but it provides advice as to how to optimise the potential use of ICM in patients after ESUS in the Polish setting.

show abstract

Global Stroke Belt

Cited by 117 publications

References 36 publications

The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey

The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey

Mortality of Stroke and Its Subtypes in China: Results from a Nationwide Population-Based Survey

Statement by a Working Group conceived by the Polish National Consultants in Cardiology and Neurology addressing the use of implantable cardiac monitors in patients after ischaemic embolic stroke of undetermined source

Contact Info

Product

Resources

About